Mutations Enhance the Aggregation Propensity of the Alzheimer's Aβ Peptide

Journal of Molecular Biology

Volumn 377, Issue 2, 2008, Pages 565-574

  Kim, Woojin ^a   Hecht, Michael H ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

aggregation; Alzheimer's disease; amyloid beta; amyloid fibril; high throughput screen

Indexed keywords

AMYLOID BETA PROTEIN; GREEN FLUORESCENT PROTEIN;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; GENE FUSION; GENE MUTATION; GENETIC SCREENING; HYDROPHOBICITY; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION;

ESCHERICHIA COLI;

EID: 40049110948     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.12.079     Document Type: Article

References (47)

1. D.J. Selkoe Alzheimer’s disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
2. A.E. Roher J.D. Lowenson S. Clarke A.S. Woods R.J. Cotter E. Gowing M.J. Ball β-Amyloid-(1–42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease Proc. Natl Acad. Sci. USA 90 1993 10836 10840
3. J.T. Jarrett E.P. Berger P.T. Lansbury Jr The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer’s disease Biochemistry 32 1993 4693 4697
4. J.D. Harper P.T. Lansbury Jr Models of amyloid seeding in Alzheimer’s disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins Annu. Rev. Biochem. 66 1997 385 407
5. J.A. Hardy G.A. Higgins Alzheimer’s disease: the amyloid cascade hypothesis Science 256 1992 184 185
6. T. Tomita S. Tokuhiro T. Hashimoto K. Aiba T.C. Saido K. Maruyama T. Iwatsubo Molecular dissection of domains in mutant presenilin 2 that mediate overproduction of amyloidogenic forms of amyloid β-peptides J. Biol. Chem. 273 1998 21153 21160
7. T. Ikeuchi G. Dolios S.-H. Kim R. Wang S.S. Sisodia Familial Alzheimer disease-linked presenilin 1 variants enhanced production of both Aβ1–40 and Aβ1–42 peptides that are only partially sensitive to a potent aspartyl protease transition state inhibitor of “γ-secretase” J. Biol. Chem. 278 2003 7010 7018
8. C. De Jonghe C. Zehr D. Yager C.-M. Prada S. Younkin L. Hendriks Flemish and Dutch mutations in amyloid β precursor protein have different effects on amyloid β secretion Neurobiol. Dis. 5 1998 281 286
9. X. Sun Y. Tong H. Qing C.-H. Chen W. Song Increased BACE1 maturation contributes to the pathogenesis of Alzheimer’s disease in Down syndrome FASEB J. 20 2006 1361 1368
10. A.M. Cataldo S. Petanceska N.B. Terio C.M. Peterhoff R. Durham M. Mercken Aβ localization in abnormal endosomes: association with earliest Aβ elevations in AD and Down syndrome Neurobiol. Aging 25 2004 1263 1272
11. E. Head I.T. Lott Down syndrome and β-amyloid deposition Curr. Opin. Neurol. 17 2004 95 100
12. J.K. Teller C. Russo L.M. DeBusk G. Angelini D. Zaccheo F. Dagna-Bricarelli Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down’s syndrome Nat. Med. 2 1996 93 95
13. K. Johnson-Wood M. Lee R. Motter K. Hu G. Gordon R. Barbour Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease Proc. Natl Acad. Sci. USA 94 1997 1550 1555
14. D.C. Crowther K.J. Kinghorn E. Miranda R. Page J.A. Curry F.A. Duthie Intraneural Aβ, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer’s disease Neuroscience 132 2005 123 135
15. C. Link A. Taft V. Kapulkin K. Duke S. Kim Q. Fei Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer’s disease model Neurobiol. Aging 24 2003 397 413
16. D.-S. Wang D.W. Dickson J.S. Malter β-Amyloid degradation and Alzheimer’s disease J. Biomed. Biotechnol. 2006 2006 1 12
17. J.S. Miners Z. Van Helmond K. Chalmers G. Wilcock S. Love P.G. Kehoe Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy J. Neuropathol. Exp. Neurol. 65 2006 1012 1021
18. E.A. Eckman S.K. Adams F.J. Troendle B.A. Stodola M.A. Kahn A.H. Fauq Regulation of steady-state β-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme J. Biol. Chem. 281 2006 30471 30478
19. R. Russo R. Borghi W. Markesbery M. Tabaton A. Piccini Neprilysin decreases uniformly in Alzheimer’s disease and in normal aging FEBS Lett. 579 2005 6027 6030
20. R. Poirier D.P. Wolfer H. Welzl J. Tracy M.J. Galsworthy R.M. Nitsch M.H. Mohajeri Neuronal neprilysin overexpression is associated with attenuation of Aβ-related memory deficit Neurobiol. Dis. 24 2006 475 483
21. S. Lesne M.T. Koh L. Kotilinek R. Kayed C.G. Glabe A. Yang A specific amyloid-β protein assembly in the brain impairs memory Nature 440 2006 352 357
22. D.M. Walsh M. Townsend M.B. Podlisny G.M. Shankar J.V. Fadeeva O.E. Agnaf Certain inhibitors of synthetic amyloid β-peptide (Aβ) fibrillogenesis block oligomerization of natural Aβ and thereby rescue long-term potentiation J. Neurosci. 25 2005 2455 2462
23. D.M. Walsh I. Klyubin J.V. Fadeeva W.K. Cullen R. Anwyl M.S. Wolfe Naturally secreted oligomers of amyloid-β protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
24. C. Wurth N.K. Guimard M.H. Hecht Mutations that reduce aggregation of the Alzheimer’s Aβ42 peptide: an unbiased search for the sequence determinants of Aβ amyloidogenesis J. Mol. Biol. 319 2002 1279 1290
25. W. Kim M.H. Hecht Generic hydrophobic residues are sufficient to promote aggregation of the Alzheimer’s Aβ42 peptide Proc. Natl Acad. Sci. USA 103 2006 15824 15829
26. W. Kim M.H. Hecht Sequence determinants of enhanced amyloidogenicity of Alzheimer Aβ42 peptide relative to Aβ40 J. Biol. Chem. 280 2005 35069 35076
27. A.D. Williams E. Portelius I. Kheterpal J. Guo K.D. Cook Y. Xu R. Wetzel Mapping Aβ amyloid fibril secondary structure using scanning proline mutagenesis J. Mol. Biol. 335 2004 833 842
28. A. Morimoto K. Irie K. Murakami Y. Masuda H. Ohigashi M. Nagao Analysis of the secondary structure of β-amyloid (Aβ42) fibrils by systematic proline replacement J. Biol. Chem. 27 2004 52781 52788
29. F. Chiti M. Stefani N. Taddei G. Ramponi C.M. Dobson Rationalization of the effects of mutations on peptide and protein aggregation rates Nature 424 2003 805 808
30. F. Massi D. Klimov D. Thirumalai J.E. Straub Charge states rather than propensity for β-structure determine enhanced fibrillogenesis in wild-type Alzheimer’s β-amyloid peptide compared to E22Q Dutch mutant Protein Sci. 11 2002 1639 1647
31. G.S. Waldo B.M. Standish J. Berendzen T.C. Terwilliger Rapid protein-folding assay using green fluorescent protein Nat. Biotechnol. 17 1999 691 695
32. W. Kim Y. Kim J. Min D. Kim Y. Chang M. Hecht A high-throughput screen for compounds that inhibit aggregation of the Alzheimer’s peptide ACS Chem. Biol. 1 2006 461 469
33. J.T. Jarrett P.T. Lansbury Jr Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer’s disease and scrapie? Cell 73 1993 1055 1058
34. H. Levine III Thioflavin T interaction with synthetic Alzheimer’s disease β-amyloid peptides: detection of amyloid aggregation in solution Protein Sci. 2 1993 404 410
35. J. Davis W.E. Van Nostrand Enhanced pathologic properties of Dutch-type mutant amyloid β-protein Proc. Natl Acad. Sci. USA 93 1996 2996 3000
36. A.T. Petkova W.-M. Yau R. Tycko Experimental constraints on quaternary structure in Alzheimer’s β-amyloid fibrils Biochemistry 45 2006 498 512
37. A.T. Petkova R. Leapman Z. Guo W. Yau M. Mattson R. Tycko Self-propagating, molecular-level polymorphism in Alzheimer’s β-amyloid fibrils Science 307 2005 262 265
38. A. Petkova Y. Ishii J. Balbach O. Antzutkin R. Leapman F. Delaglio R. Tycko A structural model for Alzheimer’s β-amyloid fibrils based on experimental constraints from solid state NMR Proc. Natl Acad. Sci. USA 99 2002 16742 16747
39. T. Lührs C. Ritter M. Adrian D. Riek-Loher B. Bohrmann H. Döbeli 3D structure of Alzheimer’s amyloid-β(1–42) fibrils Proc. Natl Acad. Sci. USA 102 2005 17342 17347
40. B.M. Broome M.H. Hecht Nature disfavors sequences of alternating polar and nonpolar amino acids: implications for amyloidogenesis J. Mol. Biol. 296 2000 961 968
41. K.F. Dubay A.P. Pawar F. Chiti J. Zurdo C.M. Dobson M. Vendruscolo Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains J. Mol. Biol. 341 2004 1317 1326
42. L.M. Luheshi G.G. Tartaglia A.C. Brorsson A.P. Pawar I.E. Watson F. Chiti Systematic in vivo analysis of the intrinsic determinants of amyloid β pathogenicity PLoS Biol. 5 2007 2493 2500
43. W.E. Van Nostr J.P. Melchor H.S. Cho S.M. Greenberg G.W. Rebeck Pathogenic effects of D23N Iowa mutant amyloid β-protein J. Biol. Chem. 276 2001 32860 32866
44. C. Nilsberth A. Westlind-Danielsson C.B. Eckman M.M. Condron K. Axelman C. Forsell The ‘Arctic’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Aβ protofibril formation Nat. Neurosci. 4 2001 887 893
45. B. Whalen D.J. Selkoe D. Hartley Small non-fibrillar assemblies of amyloid-β protein bearing the Arctic mutation induce rapid neuritic degeneration Neurobiol. Dis. 20 2005 254 266
46. M. Zaccolo D. Williams D. Brown E. Gherardi An approach to random mutagenesis of DNA using mixtures of triphosphate derivatives of nucleoside analogues J. Mol. Biol. 255 1996 589 603
47. S. Jao K. Ma J. Talafous R. Orlando M.G. Zagorski Trifluoroacetic acid pretreatment reproducibly disaggregates the amyloid-β peptide Amyloid J. Int. Exp. Clin. Invest. 4 1997 240 252